Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma.

MLA

Wong, Jason P., et al. “Kinome Profiling of Non-Hodgkin Lymphoma Identifies Tyro3 as a Therapeutic Target in Primary Effusion Lymphoma.” Proceedings of the National Academy of Sciences of the United States of America, vol. 116, no. 33, Aug. 2019, pp. 16541–50. EBSCOhost, https://doi.org/10.1073/pnas.1903991116.

APA

Wong, J. P., Stuhlmiller, T. J., Giffin, L. C., Carolina Lin, Bigi, R., Jichen Zhao, Weihe Zhang, Cruz, A. G. B., Park, S. I., Earp, H. S., Dittmer, D. P., Frye, S. V., Xiaodong Wang, Johnson, G. L., & Damania, B. (2019). Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 116(33), 16541–16550. https://doi.org/10.1073/pnas.1903991116

Chicago

Wong, Jason P., Timothy J. Stuhlmiller, Louise C. Giffin, Carolina Lin, Rachele Bigi, Jichen Zhao, Weihe Zhang, et al. 2019. “Kinome Profiling of Non-Hodgkin Lymphoma Identifies Tyro3 as a Therapeutic Target in Primary Effusion Lymphoma.” Proceedings of the National Academy of Sciences of the United States of America 116 (33): 16541–50. doi:10.1073/pnas.1903991116.